华东医药

- 000963

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
华东医药(000963) 利润表
单位:万元
报表日期2024-03-312023-12-312023-09-302023-06-302023-03-31
一、营业总收入1,041,080.914,062,378.253,039,453.052,038,534.431,011,453.13
营业收入1,041,080.914,062,378.253,039,453.052,038,534.431,011,453.13
二、营业总成本933,135.753,708,191.512,753,950.521,844,362.29911,122.15
营业成本707,639.712,746,173.162,071,143.351,391,741.81679,072.42
营业税金及附加5,633.4623,259.0315,506.3910,668.565,315.00
销售费用157,426.19664,541.14466,235.05308,378.60164,261.66
管理费用33,516.92142,018.90110,583.6172,147.7933,008.61
财务费用755.505,118.986,403.325,584.822,915.08
研发费用28,163.98127,080.3184,078.8155,840.7126,549.37
资产减值损失----------
公允价值变动收益-2.54-1,375.64-661.66-510.07--
投资收益-4,716.34-21,971.30-16,884.29-13,688.50-6,175.27
其中:对联营企业和合营企业的投资收益-3,750.45-18,839.06-14,531.42-12,042.92-5,281.69
汇兑收益----------
三、营业利润107,209.58345,292.72270,857.28179,846.0995,393.98
加:营业外收入129.565,054.88353.70297.28138.92
减:营业外支出520.263,749.032,400.011,629.86604.92
其中:非流动资产处置损失----------
四、利润总额106,818.88346,598.58268,810.97178,513.5294,927.98
减:所得税费用20,794.3361,958.8849,456.0834,527.9418,935.43
五、净利润86,024.55284,639.69219,354.88143,985.5775,992.55
归属于母公司所有者的净利润86,241.16283,886.05218,904.68143,382.4675,528.50
少数股东损益-216.60753.64450.20603.11464.05
六、每股收益
基本每股收益(元/股)0.49291.62191.25100.81940.4316
稀释每股收益(元/股)0.49281.62071.25030.81900.4315
七、其他综合收益4,058.955,050.65-388.90-888.94-3,135.14
八、综合收益总额90,083.51289,690.34218,965.99143,096.6372,857.41
归属于母公司所有者的综合收益总额90,300.11288,936.70218,515.79142,493.5272,393.36
归属于少数股东的综合收益总额-216.60753.64450.20603.11464.05
下载全部历史数据到excel中 返回页顶